Monitor Quote Charts Trades News Financials Toplists Alerts Portfolio Level 2 Forex Boards
  24/11/2009
00:31:43
Site map		   Help
 
Sangamo Biosciences (MM)
   
To register click here

Sangamo Biosciences Stock Price SGMO

Sangamo Biosciences stock quote | Sangamo Biosciences company information | Sangamo Biosciences Stock Chart | Sangamo Biosciences Stock News

Company Description : The company is engaged in the research, development and commercialization of novel transcription factors for gene regulation and gene modification. url: www.sangamo.com

Name:
Sangamo Biosciences (MM)		 Symbol:
NASDAQ:SGMO		 Stock Market:
NASDAQ Stock Market		 Type:
Common Stock		 ISIN:
 Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
-0.15-2.725.365.155.985.765.335.581792507:22:01
To register Click hereRegister for free Sangamo Biosciences stock prices.

Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS : RICHMOND, Calif., Nov. 18 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (NASDAQ:SGMO) announced today that data from the University of Pennsylvania investigator sponsored Phase 1 safety study of Sangamo's zinc finger...

Free Sangamo Biosciences Stock Charts

Sangamo Biosciences Historical Stock Chart
Sangamo Biosciences Historical Stock Chart
Sangamo Biosciences Monthly Stock Chart
Sangamo Biosciences Monthly Stock Chart		Sangamo Biosciences Intraday stock chart
Sangamo Biosciences Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Sangamo Biosciences stock Price, quotes, trades and FREE Sangamo Biosciences stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Sangamo Biosciences (SGMO) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Sangamo Biosciences News & Message Board Discussion

Latest Sangamo Biosciences News Headlines
DateTimeSource
Headline
11/18/20093:30PMPRNUSSangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
11/04/20094:02PMPRNUSSangamo BioSciences Reports Third Quarter 2009 Financial Results
11/03/20094:05PMPRNUSSangamo BioSciences Announces Presentation at Merriman Curhan Ford's Investor Summit 2009
10/28/20094:05PMPRNUSSangamo BioSciences Announces Third Quarter 2009 Conference Call and Webcast
10/28/20094:02PMPRNUSSangamo BioSciences Research Collaborators Awarded Grant From California Institute for Regenerative Medicine to Develop Zinc Fin
10/20/20092:00PMPRNUSSangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society
10/13/200912:30PMPRNUSSangamo Announces Closing of Common Stock Offering
10/07/20099:15AMPRNUSSangamo Announces Pricing of Public Offering of Common Stock
10/05/20097:00AMPRNUSSigma-Aldrich(R) and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement
10/01/20097:00AMPRNUSSangamo BioSciences Announces Research Collaboration With UCLA in Human Stem Cells Selected to Receive Clinical Research Award
09/28/20094:05PMPRNUSSangamo BioSciences Announces Presentation at the JMP Securities Healthcare Conference
09/23/20097:00AMPRNUSSangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
Latest Message Board Discussions
DateTime
TitleMore
10/28/20094:39PMSangamo BioSciences Research Collaborators Awarded Grant From California
10/07/20098:31AMSangamo BioSci SGMO Leerink Swann upgraded to
10/05/20099:02AM7:03AM Sangamo BioSci and Sigma-Aldrich announce major expansion
10/01/20098:42AMSangamo BioSciences Announces Research Collaboration With UCLA in
09/16/200910:52AMRecent News
09/16/200910:52AMRecent News
05/13/20094:10PMSangamo BioSciences Announces Presentation at the JMP Securities
05/04/20097:59PMSangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant
04/29/20091:12PMSangamo BioSciences Announces Publication in Nature of the
04/17/20099:30PMStarting to see some volume

Sangamo Biosciences Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Sangamo Biosciences company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Sangamo Biosciences Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  1051 5.36 11/23/2009 4:17PM USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
32 site:2us nasdaq sgmo091124 00:31 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )